These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9124849)

  • 21. Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
    Triger DR; Granai F; Woodcock J; Wise R; Imbimbo BP
    Hepatology; 1993 Oct; 18(4):847-52. PubMed ID: 8406358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sparfloxacin pharmacokinetics in healthy volunteers: the influence of acidification and alkalinization.
    Kamberi M; Kotegawa T; Tsutsumi K; Nakamura K; Nakano S
    Eur J Clin Pharmacol; 1998 Oct; 54(8):633-7. PubMed ID: 9860151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects.
    Bron NJ; Dorr MB; Mant TG; Webb CL; Vassos AB
    J Antimicrob Chemother; 1996 Dec; 38(6):1023-9. PubMed ID: 9023649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review.
    Montay G
    J Antimicrob Chemother; 1996 May; 37 Suppl A():27-39. PubMed ID: 8737123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antacid medication on the pharmacokinetics of temafloxacin.
    Granneman GR; Stephan U; Birner B; Sörgel F; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():83-9. PubMed ID: 1319875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the new fluoroquinolone balofloxacin and its metabolites in biological fluids by high performance liquid chromatography.
    Nakagawa T; Ishigai M; Hiramatsu Y; Kinoshita H; Ishitani Y; Ohkubo K; Okazaki A
    Arzneimittelforschung; 1995 Jun; 45(6):716-8. PubMed ID: 7646578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolones in the aged.
    Nicolle LE
    Drugs; 1999; 58 Suppl 2():49-51. PubMed ID: 10553705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA; Schultz RW; Schentag JJ
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2364-8. PubMed ID: 2088191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and ocular penetration of grepafloxacin in albino and pigmented rabbits.
    Perez S; Solans C; Bregante MA; Pinilla I; García MA; Honrubia F
    J Antimicrob Chemother; 2002 Oct; 50(4):541-5. PubMed ID: 12356799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
    Kovarik JM; Hoepelman AI; Smit JM; Sips PA; Rozenberg-Arska M; Glerum JH; Verhoef J
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2458-61. PubMed ID: 1336948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High performance liquid chromatography and preliminary pharmacokinetics of rufloxacin and its metabolites N-desmethylrufloxacin and rufloxacinsulfoxide in plasma and urine of humans.
    Vree TB; van den Biggelaar-Martea M; Imbimbo BP
    Eur J Drug Metab Pharmacokinet; 1992; 17(1):45-9. PubMed ID: 1323466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
    Meyerhoff C; Dilger C; Yoon SJ; Chung YH; Lee DK; Lee CW; Ryu JM; Choi MS; Pabst G; Reh C
    J Antimicrob Chemother; 1998 Sep; 42(3):349-61. PubMed ID: 9786475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of temafloxacin after multiple oral administration.
    Granneman GR
    Clin Pharmacokinet; 1992; 22 Suppl 1():14-23. PubMed ID: 1319867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gallbladder tissue concentrations, biliary excretion and pharmacokinetics of OPC-17116.
    Tanimura H; Uchiyama K; Kashiwagi H
    Drugs; 1995; 49 Suppl 2():341-3. PubMed ID: 8549355
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of grepafloxacin in plasma and urine by a simple and rapid high-performance liquid chromatographic method.
    Kamberi M; Kamberi P; Nakano S
    J Chromatogr B Biomed Sci Appl; 2000 May; 741(2):295-300. PubMed ID: 10872599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grepafloxacin.
    Wagstaff AJ; Balfour JA
    Drugs; 1997 May; 53(5):817-24; discussion 825-7. PubMed ID: 9129868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.
    Stroshane RM; Silverman MH; Sauerschell R; Brown RR; Boddy AW; Cook JA
    Antimicrob Agents Chemother; 1990 May; 34(5):751-4. PubMed ID: 2360815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine.
    Post LO; Farrell DE; Cope CV; Baker JD; Myers MJ
    J Pharmacol Exp Ther; 2003 Feb; 304(2):889-95. PubMed ID: 12538847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and safety of NM441, a new quinolone, in healthy male volunteers.
    Nakashima M; Uematsu T; Kosuge K; Okuyama Y; Morino A; Ozaki M; Takebe Y
    J Clin Pharmacol; 1994 Sep; 34(9):930-7. PubMed ID: 7983237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.